文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

急诊科静脉注射对乙酰氨基酚与静脉注射氢吗啡酮治疗急性疼痛的随机对照试验

Randomized Controlled Trial of Intravenous Acetaminophen Versus Intravenous Hydromorphone for the Treatment of Acute Pain in the Emergency Department.
PubMed 文献 · Ann Emerg Med · 2018-08-14
一句话结论在急诊成人重度急性疼痛中,静脉注射氢吗啡酮1 mg的60分钟镇痛效果优于静脉注射对乙酰氨基酚1 g,但恶心呕吐发生率更高。

这项前瞻性随机临床试验比较了静脉注射对乙酰氨基酚1 g与静脉注射氢吗啡酮1 mg在急诊成人重度急性疼痛中的效果。主要终点为给药后60分钟数字评定量表(NRS)评分较基线的变化。结果显示,氢吗啡酮组NRS平均下降5.3,对乙酰氨基酚组下降3.3,组间差异2.0(95%CI 1.2至2.7), favoring氢吗啡酮。氢吗啡酮组更多患者在60分钟时拒绝额外镇痛(65% vs 44%),但恶心(19% vs 3%)和呕吐(14% vs 3%)发生率显著更高。

要点

  • 在急诊成人重度急性疼痛中,静脉注射氢吗啡酮1 mg在60分钟时的NRS评分下降幅度(5.3)大于静脉注射对乙酰氨基酚1 g(3.3),组间差异2.0(95%CI 1.2至2.7)。
  • 氢吗啡酮组60分钟时拒绝额外镇痛的患者比例更高(65% vs 44%,差异21%,95%CI 8%至35%)。
  • 两组在60分钟前接受补救镇痛的比例无差异。
  • 氢吗啡酮组恶心发生率19% vs 对乙酰氨基酚组3%(差异16%,95%CI 4%至28%),呕吐发生率14% vs 3%(差异11%,95%CI 0%至23%)。

适用人群与场景

  • 急诊科就诊的成人患者,表现为重度急性疼痛。

处置流程与药物剂量

  • 静脉注射对乙酰氨基酚1 g与静脉注射氢吗啡酮1 mg作为研究干预进行比较,用于急诊成人重度急性疼痛。

研究设计与关键结果

  • 前瞻性随机临床试验,220例随机,每组103例有足够数据进行分析;比较静脉注射对乙酰氨基酚1 g与静脉注射氢吗啡酮1 mg。
  • 主要终点:60分钟时NRS评分平均下降氢吗啡酮组5.3 vs 对乙酰氨基酚组3.3,差异2.0(95%CI 1.2至2.7), favoring氢吗啡酮。
  • 次要终点:60分钟时拒绝额外镇痛比例氢吗啡酮组65% vs 对乙酰氨基酚组44%,差异21%(95%CI 8%至35%)。
  • 次要终点:60分钟前接受补救镇痛比例两组无差异。
  • 不良事件:恶心氢吗啡酮组19% vs 对乙酰氨基酚组3%,差异16%(95%CI 4%至28%);呕吐氢吗啡酮组14% vs 对乙酰氨基酚组3%,差异11%(95%CI 0%至23%)。

证据类型、等级与局限

  • 证据类型:前瞻性随机临床试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于急诊成人重度急性疼痛,静脉注射氢吗啡酮1 mg较静脉注射对乙酰氨基酚1 g提供更大的60分钟镇痛效果,但需注意恶心和呕吐发生率的增加。
  • 两组在60分钟前接受补救镇痛的比例无差异。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

STUDY OBJECTIVE: As clinicians look to nonnarcotic analgesics in the emergency department (ED), it is essential to understand the effectiveness and adverse effects of nonopioid medications in comparison with existing opioid treatments. Studies of intravenous acetaminophen for acute pain in the ED demonstrate mixed results and suffer from small sample sizes and methodological limitations. This study compares intravenous hydromorphone with intravenous acetaminophen in adult ED patients presenting with acute pain.

METHODS: This was a prospective, randomized, clinical trial comparing 1 g intravenous acetaminophen with 1 mg intravenous hydromorphone for treatment of adults with severe, acute pain in the ED. The primary outcome was between-group difference in change in numeric rating scale from baseline to 60 minutes postadministration of study medication. Secondary outcomes included the difference in proportion of patients in each group who declined additional analgesia at 60 minutes, received additional medication before 60 minutes, and developed nausea, vomiting, or pruritus.

RESULTS: Of 220 subjects randomized, 103 patients in each arm had sufficient data for analysis. At 60 minutes, the mean decrease in numeric rating scale pain score was 5.3 in the hydromorphone arm and 3.3 in the acetaminophen arm, a difference of 2.0 (95% confidence interval [CI] 1.2 to 2.7) favoring hydromorphone. A greater proportion of patients in the hydromorphone arm also declined additional analgesia at 60 minutes (65% versus 44%; difference 21%; (95% CI 8% to 35%). There was no difference in the proportion of patients receiving rescue analgesia before 60 minutes. Significantly more subjects in the hydromorphone group developed nausea (19% versus 3%; difference 16%; 95% CI 4% to 28%) and vomiting (14% versus 3%; difference 11%; 95% CI 0% to 23%).

CONCLUSION: Although both 1 mg intravenous hydromorphone and 1 g intravenous acetaminophen provided clinically meaningful reductions in pain scores, treatment with hydromorphone provided both clinically and statistically greater analgesia than acetaminophen, at the cost of a higher incidence of nausea and vomiting.

来源:Ann Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Barnaby DP, Chertoff AE, Restivo AJ, et al. Randomized Controlled Trial of Intravenous Acetaminophen Versus Intravenous Hydromorphone for the Treatment of Acute Pain in the Emergency Department. Ann Emerg Med. 2018. PMID: 30119941. doi:10.1016/j.annemergmed.2018.06.019

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。